Alexion Pharmaceuticals Inc. Stock Calculator

Use Alexion Pharmaceuticals Inc. stock calculator to calculate potential returns on Alexion Pharmaceuticals Inc. stock over time. Enter your investment amount and select a timeframe to see historical performance, total returns, and average annual growth.

Select stock to calculate:

Amount

$0$10,000

Years Ago

11y301y

If you had invested $--- in Alexion Pharmaceuticals Inc. --- years ago, you would have $--- today

Total Return

---

Annual Return

---

Stock CFDs Ready to start trading?

Alexion Pharmaceuticals Inc.

Alexion Pharmaceuticals Inc. is a biopharmaceutical company. The company was founded in 1992 and is headquartered in Boston, Massachusetts. The Company is focused on the development and commercialization of therapeutic products. The Company's products include Soliris (eculizumab), Strensiq (asfotase alfa) and Kanuma (sebelipase alfa). The Company's clinical development programs include Soliris (eculizumab), cPMP (ALXN1101), SBC-103, ALXN1210 (IV) and ALXN1210 (Subcutaneous). Its Soliris is the therapeutic approved for patients with either paroxysmal nocturnal hemoglobinuria (PNH) or hemolytic uremic syndrome (aHUS). PNH and aHUS result from chronic uncontrolled activation of the complement component of the immune system. Its Strensiq is for the treatment of patients with Hypophosphatasia (HPP). Its product, Kanuma is for the treatment of patients with Lysosomal Acid Lipase Deficiency (LAL-D). It is a recombinant form of the human LAL enzyme, which is a replacement therapy that is approved for the treatment for patients with LAL-D.